TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in bacterial concentrations greater than 10^5 CFU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: sterile syringe use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fraction of Participants With Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Grades 1-5 Serious and/or Non-serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of INOCA in women vs. men
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hopkins Verbal Learning Test Revised (HVLT-R)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Circulating Level of SPMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International restless legs syndrome study group rating scale (IRLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Scale for Children with Type 1 Diabetes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percent difference between initial reference plan and adaptive weekly RT plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of deformable imaging registration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corticospinal Tract Excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reticulospinal Tract Excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Objective Structured Clinical Exam (OSCE) performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MdAPE difference for propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MdAPE difference for remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in %BMIp95
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Existence of at least one fall
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Analog Scale (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Patients with Pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of primary and secondary graft failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation Severity Instrument (CSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient Assessment of Constipation- Quality of Life (PAC-QOL) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in KAP assessment score on dengue fever prevention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean dynamic VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically Significant Changes in Safety Tests
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of complications related to rectal anastomosis
Endpoint domain: Adverse events/effects
Primary endpoint: Taxonomic faecal microbiota description
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemagglutination inhibition (HI) titers against vaccine A and B influenza strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Collection of bile samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of all device related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Magnitude of non-suppressible and renin-independent aldosterone production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in time in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor-to-Background Ratio (TBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in dopamine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in serotonin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Brain-Derived Neurotrophic factor (BDNF) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Nerve Growth Factor (NGF) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Remission of insomnia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: postoperative FLACC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Purpose in life test
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Work Extrinsic and Intrinsic Motivation Scale (WEIMS)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Life and productivity test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vasopressor dose in Nor-epinephrine equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to suitability for grafting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: self-efficacy for symptom management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: symptom self-management behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Virtual Reality Attentional Bias (VR-AB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nicotine use episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of the Most Bothersome Symptom (MBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability as determined by adverse events and dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of HAE attacks per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy of VYN201 compared to vehicle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HF (ms^2) Component of HRV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change scores on the Face-Name Associative Memory Exam
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change scores on the Visual Short-Term Memory Binding Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change scores on the Spatial pattern separation test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Spielberger State-Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in researcher-designed attention scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Trail Making Test, Part A and B
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total exogenous carbohydrate oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Body Weight (BW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Waist to Hip Ratio (WHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Body Fat (BF%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Weight-for- Age Growth Charts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Finger Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CR rate after 6 cycles of induction therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief measured by Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Scarless Labs Observer Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in scores of International Trauma Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anti-XBB-specific neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complete closure rate of great saphenous vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Accuracy of differential diagnosis between benign and malignant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of persons screened for depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Hematologic Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ratio of sodium to potassium (Na/K) in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: postoperative visual analog scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final pathology diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete wound closure at Week 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aspiration pneumonia incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Dialysis treatment adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants with Treatment Emergent Adverse Events (TEAE'S)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Matching Glucose Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Evaluation of Ability to Sing Easily
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Seroconversion rates of anti-HPV 16 and 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates of anti-measles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates of anti-rubella
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates of anti-mumps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of failure
Endpoint domain: Mortality/survival
Primary endpoint: Pain in the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep quantity school days
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep quantity free days
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep quality - general
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in self-reported ART adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: non-invasive tear break-up time (NITBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of times the software is used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of adverse events related to the device
Endpoint domain: Adverse events/effects
Primary endpoint: Average minimum Euclidean distance from CD8+ T cells to TAMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change in weight in excess of the 95th percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Youth Self Report (YSR) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of foot ulceration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in phase of chronic cardiomyopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Major Adverse Cardiac Events (MACE), Arterial Occlusive Events (AOEs), and Venous Thrombotic Events (VTEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Lesional CD4+ T effector cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lesional CD8+ T effector cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: recruitment yield
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Health Protection and Promotion Behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Elderly Health Promotion
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: General Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Health Seeking Behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Superficial surgical site infection (sSSI)
Endpoint domain: Adverse events/effects
Primary endpoint: low-density lipoproteins (LDL) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of asthma control during the treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who self-refer to cancer clinical trials
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rett Syndrome: Symptom Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postoperative Quality of Recovery 15 functional recovery score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Distant Metastasis-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in VSQ Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: COVID-19 vaccine confidence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maternal and fetal vitamin D level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Readiness to change self-care engagement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in corneal endothelial cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in intraocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean efficiency change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GOT (Glutamic Oxaloacetic Transaminase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GPT (Glutamic Pyruvic Transaminase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disabilities of the Arm, Shoulder and Hand (Quick DASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Childrens Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcriptome analysis of patients' platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolomics analysis of patients' platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proteomics analysis of patients' platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of pain experienced during episiotomy incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of pain experienced during episiotomy repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of fear experienced during episiotomy incision
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Score of fear experienced during episiotomy repair
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Financial Strain
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Resourcefulness
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Protein changes in Platelet Rich Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized Concussion Assessment Tool (SCAT6) assessment outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum Tolerated Dose of N-Acetyl-Cysteine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose Limited Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: ACC0 of machine rating vs gold standard rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACC1 of machine rating vs gold standard rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weighted kappa of machine rating vs gold standard rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lin's CCC of machine rating vs gold standard rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titer (GMT) of SARS-Cov-2 Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional connectivity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Curve for Receiver Operating Characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of alcoholic drinks consumed per week at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of heavy episodic drinking days the past month at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rating of pain severity and interference at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of the Grippol Quadrivalent vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cognition - Global
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 26 week sustained overall response to ITP treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Salivary Alpha-Amylase Concentrations before and after dental procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in gait performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in gait quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in global motor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Service Utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Baropodometric measurements of plantar pressure distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Brain Natriuretic Peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concentration of myocardial enzyme
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concentration of troponin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Negative urine culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: sensitivity and specificity of the construction test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate of corneal basement membrane dystrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of device-related or likely related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Breastfeeding Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: European Heart Rhythm Association (EHRA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of repetitions in 30-second sit-to-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major adverse cardiovascular event (MACE) at 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: Posttraumatic Stress Disorder Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Shame
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Root migration distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net adverse clinical event
Endpoint domain: Adverse events/effects
Primary endpoint: Symptom Checklist Scale (SCL 90) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in Bone Turnover Markers (BTMs) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in Bone Turnover Markers (BTMs) at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes